SLC6A2 and PPP2R1A

Number of citations of the paper that reports this interaction (PMID 15963952)
12

Data Source:
HPRD (in vivo)

		SLC6A2	PPP2R1A
Gene Name		solute carrier family 6 (neurotransmitter transporter), member 2	protein phosphatase 2, regulatory subunit A, alpha
Image		No pdb structure
Gene Ontology Annotations	Cellular Component	Plasma Membrane Integral Component Of Plasma Membrane Cell Surface Membrane Neuron Projection Membrane Raft	Protein Phosphatase Type 2A Complex Chromosome, Centromeric Region Nucleus Mitochondrion Cytosol Microtubule Cytoskeleton Membrane Extracellular Vesicular Exosome
	Molecular Function	Norepinephrine:sodium Symporter Activity Protein Binding Monoamine Transmembrane Transporter Activity Alpha-tubulin Binding Beta-tubulin Binding	Antigen Binding Protein Serine/threonine Phosphatase Activity Protein Binding Protein Phosphatase Type 2A Regulator Activity Protein Heterodimerization Activity
	Biological Process	Transport Neurotransmitter Transport Synaptic Transmission Monoamine Transport Norepinephrine Transport Response To Drug Response To Pain Transmembrane Transport	G2/M Transition Of Mitotic Cell Cycle Nuclear-transcribed MRNA Catabolic Process, Nonsense-mediated Decay Inactivation Of MAPK Activity Mitotic Cell Cycle Regulation Of DNA Replication Regulation Of Transcription, DNA-templated Protein Complex Assembly Protein Dephosphorylation Ceramide Metabolic Process Apoptotic Process Organelle Organization Chromosome Segregation Mitotic Nuclear Envelope Reassembly RNA Splicing Fibroblast Growth Factor Receptor Signaling Pathway Response To Organic Substance Gene Expression Second-messenger-mediated Signaling Regulation Of Wnt Signaling Pathway Regulation Of Cell Adhesion Negative Regulation Of Cell Growth Regulation Of Growth Negative Regulation Of Tyrosine Phosphorylation Of Stat3 Protein Regulation Of Cell Differentiation Peptidyl-serine Dephosphorylation Positive Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand
Pathways		Na+/Cl- dependent neurotransmitter transporters Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds SLC-mediated transmembrane transport	Signaling by FGFR in disease Integration of energy metabolism misspliced GSK3beta mutants stabilize beta-catenin T41 mutants of beta-catenin aren't phosphorylated ERKs are inactivated Toll Like Receptor TLR1:TLR2 Cascade Glucose metabolism Degradation of beta-catenin by the destruction complex Toll Like Receptor 5 (TLR5) Cascade AXIN mutants destabilize the destruction complex, activating WNT signaling S33 mutants of beta-catenin aren't phosphorylated MyD88 dependent cascade initiated on endosome Glycogen storage diseases Beta-catenin phosphorylation cascade Mitotic G1-G1/S phases Recruitment of mitotic centrosome proteins and complexes misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling TRIF-mediated TLR3/TLR4 signaling S45 mutants of beta-catenin aren't phosphorylated Spry regulation of FGF signaling Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) deletions in the AMER1 gene destabilize the destruction complex AMER1 mutants destabilize the destruction complex Platelet sensitization by LDL Resolution of Sister Chromatid Cohesion Toll Like Receptor 3 (TLR3) Cascade Metabolism of carbohydrates Mitotic G2-G2/M phases Adaptive Immune System MASTL Facilitates Mitotic Progression Separation of Sister Chromatids APC truncation mutants have impaired AXIN binding G2/M Transition disassembly of the destruction complex and recruitment of AXIN to the membrane Activated TLR4 signalling S37 mutants of beta-catenin aren't phosphorylated Cyclin A/B1 associated events during G2/M transition Loss of Nlp from mitotic centrosomes XAV939 inhibits tankyrase, stabilizing AXIN TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation MyD88:Mal cascade initiated on plasma membrane Innate Immune System Nonsense-Mediated Decay (NMD) E2F mediated regulation of DNA replication ERKs are inactivated G1 Phase CTLA4 inhibitory signaling Signaling by FGFR Cyclin D associated events in G1 Toll-Like Receptors Cascades Toll Like Receptor 10 (TLR10) Cascade TCF dependent signaling in response to WNT ERK/MAPK targets MAPK targets/ Nuclear events mediated by MAP kinases Signaling by WNT in cancer Inhibition of replication initiation of damaged DNA by RB1/E2F1 Signaling by GPCR Mitotic Prophase TCF7L2 mutants don't bind CTBP truncated APC mutants destabilize the destruction complex Signaling by Wnt Glycolysis Regulation of PLK1 Activity at G2/M Transition RNF mutants show enhanced WNT signaling and proliferation G1/S Transition Myoclonic epilepsy of Lafora Toll Like Receptor 9 (TLR9) Cascade Initiation of Nuclear Envelope Reformation ERK/MAPK targets truncations of AMER1 destabilize the destruction complex Negative regulation of FGFR signaling Opioid Signalling phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex AXIN missense mutants destabilize the destruction complex Toll Like Receptor 2 (TLR2) Cascade Platelet homeostasis Toll Like Receptor 4 (TLR4) Cascade Mitotic Metaphase and Anaphase PP2A-mediated dephosphorylation of key metabolic factors Mitotic Prometaphase Organelle biogenesis and maintenance Costimulation by the CD28 family Toll Like Receptor 7/8 (TLR7/8) Cascade Mitotic Anaphase APC truncation mutants are not K63 polyubiquitinated M Phase Toll Like Receptor TLR6:TLR2 Cascade MyD88 cascade initiated on plasma membrane DARPP-32 events Nuclear Envelope Reassembly Signalling by NGF MAP kinase activation in TLR cascade Assembly of the primary cilium NGF signalling via TRKA from the plasma membrane MyD88-independent cascade Anchoring of the basal body to the plasma membrane Cell Cycle, Mitotic Loss of proteins required for interphase microtubule organizationÂ from the centrosome deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling Centrosome maturation Nuclear Events (kinase and transcription factor activation)
Drugs		Phentermine Tramadol Guanadrel Sulfate Reboxetine Venlafaxine Atomoxetine Amitriptyline Protriptyline Methylphenidate Imipramine Duloxetine Nortriptyline Amoxapine Mazindol Ergotamine Paroxetine Trimipramine Phenmetrazine Pseudoephedrine Cocaine Maprotiline Diethylpropion Sibutramine Chlorpheniramine Doxepin Nefazodone Desipramine Bupropion Guanethidine Orphenadrine Escitalopram Clomipramine Ephedra Ephedrine Ginkgo biloba MMDA 3,4-Methylenedioxymethamphetamine Dextroamphetamine Methamphetamine Phendimetrazine Nomifensine Amineptine Debrisoquin Milnacipran Mianserin Tapentadol Desvenlafaxine Dexmethylphenidate Levonordefrin Levomilnacipran
Diseases
GWAS
Protein-Protein Interactions		2 interactors: PPP2R1A STX1A	39 interactors: AIMP2 AKT1 ARIH2 CDK1 CSDC2 EEF2 GNA12 GRIN1 GRIN2D HSF2 HSPD1 IPO9 MAP3K7 MAPK6 MCM3 PARK7 PLA2G16 PPP2CA PPP2R2A PPP2R3B PPP2R5A PPP4C PPP5C PRDX1 PRDX2 RAB11A RAB18 RAB7A RAP1A SGOL1 SGOL2 SLC6A2 SMAD2 SMAD3 STRN STRN3 TAB1 TRADD ZFYVE9
Entrez ID		6530	5518
HPRD ID		01232	16184
Ensembl ID		ENSG00000103546
Uniprot IDs		B4DX48 P23975	A8K7B7 P30153
PDB IDs			1B3U 2IE3 2IE4 2NPP 2NYL 2NYM 2PKG 3C5W 3DW8 3K7V 3K7W 4I5L 4I5N
Enriched GO Terms of Interacting Partners?		Peptidyl-serine Dephosphorylation Negative Regulation Of Tyrosine Phosphorylation Of Stat3 Protein Regulation Of Synaptic Vesicle Priming Synaptic Vesicle Docking Mitotic Nuclear Envelope Reassembly Synaptic Vesicle Fusion To Presynaptic Membrane Nuclear Envelope Reassembly Response To Gravity Positive Regulation Of Neurotransmitter Secretion Membrane Organization Negative Regulation Of JAK-STAT Cascade Glutamate Secretion Regulation Of Tyrosine Phosphorylation Of Stat3 Protein Inactivation Of MAPK Activity Positive Regulation Of Excitatory Postsynaptic Membrane Potential Regulation Of Synaptic Vesicle Exocytosis Positive Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand Regulation Of Synaptic Vesicle Transport Positive Regulation Of Membrane Potential Calcium Ion-dependent Exocytosis Negative Regulation Of Peptidyl-tyrosine Phosphorylation Vesicle Fusion Synaptic Vesicle Exocytosis Acid Secretion Positive Regulation Of Exocytosis Vesicle Docking Involved In Exocytosis Nuclear Envelope Organization Regulation Of Neurotransmitter Secretion Regulation Of Excitatory Postsynaptic Membrane Potential Organelle Fusion Regulation Of Postsynaptic Membrane Potential Regulation Of Cellular Component Organization Vesicle Docking Dicarboxylic Acid Transport Negative Regulation Of MAP Kinase Activity Regulation Of Extrinsic Apoptotic Signaling Pathway In Absence Of Ligand Positive Regulation Of Extrinsic Apoptotic Signaling Pathway Regulation Of JAK-STAT Cascade Membrane Docking Ceramide Metabolic Process Nuclear-transcribed MRNA Catabolic Process, Nonsense-mediated Decay Neurotransmitter Secretion Synaptic Vesicle Transport Positive Regulation Of Synaptic Transmission Membrane Depolarization G2/M Transition Of Mitotic Cell Cycle Nucleus Organization Regulation Of DNA Replication Membrane Fusion Negative Regulation Of Protein Serine/threonine Kinase Activity	Positive Regulation Of Cellular Protein Metabolic Process Positive Regulation Of Protein Metabolic Process Ras Protein Signal Transduction Signaling Intracellular Signal Transduction Signal Transduction Cell Communication Positive Regulation Of Cellular Metabolic Process SMAD Protein Complex Assembly Mitotic Cell Cycle Cellular Response To Growth Factor Stimulus Response To Growth Factor Regulation Of Signaling Cellular Response To Stimulus Cell Cycle Process Response To Organic Substance Cell Cycle Mitotic Cell Cycle Process Enzyme Linked Receptor Protein Signaling Pathway Regulation Of Cellular Protein Metabolic Process Response To Stimulus Regulation Of Signal Transduction Transforming Growth Factor Beta Receptor Signaling Pathway Protein Complex Assembly Regulation Of Protein Metabolic Process MyD88-dependent Toll-like Receptor Signaling Pathway Regulation Of Cellular Process Positive Regulation Of Metabolic Process Response To Organic Cyclic Compound Positive Regulation Of Protein Kinase Activity Cellular Response To Transforming Growth Factor Beta Stimulus Regulation Of Establishment Of Protein Localization Positive Regulation Of Protein Modification Process Response To Transforming Growth Factor Beta Positive Regulation Of Kinase Activity Negative Regulation Of Signaling Regulation Of Cysteine-type Endopeptidase Activity Involved In Apoptotic Process Apoptotic Process Regulation Of Cysteine-type Endopeptidase Activity Positive Regulation Of Signal Transduction Cellular Response To Reactive Oxygen Species Positive Regulation Of Sequence-specific DNA Binding Transcription Factor Activity Hydrogen Peroxide Metabolic Process Programmed Cell Death Cellular Component Assembly Positive Regulation Of Transferase Activity Regulation Of Phosphorylation Regulation Of Kinase Activity Regulation Of Protein Localization Toll-like Receptor Signaling Pathway
Tagcloud ?		9k arrb1 atg14 atg4b cage1 cald1 cd9 chrna7 chrnb1 col1 expressional fn1 frap hey1 humn il10r il12 il13 il15 il27 immunochemical informational kpna4 oas vegfc villi villous villus voluntarily	arid1a carcinomas ccc concurrent constitute ctnnb1 endometrial endometrioid endometrium hepatocyte hnf1beta immunophenotype mismatch morphologically mutated napsin oestrogen oncogenesis pole predominance prototypical pten pure rigorously serous tp53 tumours twelve underscore
Tagcloud (Difference) ?		9k arrb1 atg14 atg4b cage1 cald1 cd9 chrna7 chrnb1 col1 expressional fn1 frap hey1 humn il10r il12 il13 il15 il27 immunochemical informational kpna4 oas vegfc villi villous villus voluntarily	arid1a carcinomas ccc concurrent constitute ctnnb1 endometrial endometrioid endometrium hepatocyte hnf1beta immunophenotype mismatch morphologically mutated napsin oestrogen oncogenesis pole predominance prototypical pten pure rigorously serous tp53 tumours twelve underscore
Tagcloud (Intersection) ?